These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17588496)

  • 21. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries.
    Ibrahim KM; Khan S; Laaser U
    J Ayub Med Coll Abbottabad; 2002; 14(4):11-5. PubMed ID: 12688094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention.
    Schluger NW; El-Bassel N; Hermosilla S; Terlikbayeva A; Darisheva M; Aifah A; Galea S
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S32-6. PubMed ID: 23928052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia.
    Riekstina V; Leimane V; Holtz TH; Leimans J; Wells CD
    Int J Tuberc Lung Dis; 2007 May; 11(5):585-7. PubMed ID: 17439686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
    Laserson KF; Thorpe LE; Leimane V; Weyer K; Mitnick CD; Riekstina V; Zarovska E; Rich ML; Fraser HS; Alarcón E; Cegielski JP; Grzemska M; Gupta R; Espinal M
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):640-5. PubMed ID: 15971391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-related tuberculosis: how well are we doing with current control efforts?
    Maher D; Borgdorff M; Boerma T
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):17-24. PubMed ID: 15675545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TB deaths reach historic levels. International (global).
    AIDS Wkly Plus; 1996 Apr 8-15; ():14-6. PubMed ID: 12320054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor countries can move on tuberculosis and STDS. International (developing countries).
    Sex Wkly Plus; 1996; (Sample No):26-7. PubMed ID: 12320367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multidrug-resistant tuberculosis: challenges of a global emergence].
    Comolet T
    Bull Soc Pathol Exot; 2015 Oct; 108(4):290-8. PubMed ID: 26289547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human resource capacity building on TB laboratory work for TB control program--through the experience of international TB laboratory training course for TB control at the Research Institute of Tuberculosis, JATA, Japan].
    Fujiki A; Kato S
    Kekkaku; 2008 Jun; 83(6):475-9. PubMed ID: 18634453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.
    Perkins MD; Cunningham J
    J Infect Dis; 2007 Aug; 196 Suppl 1():S15-27. PubMed ID: 17624822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant tuberculosis in an HIV-infected girl.
    Shah I; Mohanty S
    Natl Med J India; 2012; 25(4):210-1. PubMed ID: 23278778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
    Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
    Caminero JA
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.